Home
Browse
Search
Statistics
About
Usage
PMID: 20799350
Kelly L, Fukushima H, Karchin R, Gow JM, Chinn LW, Pieper U, Segal MR, Kroetz DL, Sali A
Functional hot spots in human ATP-binding cassette transporter nucleotide binding domains.
Protein Sci. 2010 Nov;19(11):2110-21.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
30
ABCC6 p.Gly1302Arg
X
ABCC6 p.Gly1302Arg 20799350:30:65
status:
NEW
view ABCC6 p.Gly1302Arg details
ABCC2 p.Gln1382Arg
X
ABCC2 p.Gln1382Arg 20799350:30:195
status:
NEW
view ABCC2 p.Gln1382Arg details
Mutations in the ATP-binding site also disrupt function, such as
G1302R
in the Pseudoxanthoma elasticum- associated ABCC6 gene.15 Finally, mutations such as the Dubin-Johnson syndrome-associated
Q1382R
in ABCC2 are in a mobile region of the NBD (the ''Q-loop``) that is hypothesized to transmit a conformational change between the NBDs and TMDs of an ABC transporter.16 While it is preferable to experimentally characterize the effects of each of the thousands of reported variants in ABC transporters, this approach is not feasible given the large number of variants.
Login to comment
48
ABCC4 p.Gly487Glu
X
ABCC4 p.Gly487Glu 20799350:48:37
status:
NEW
view ABCC4 p.Gly487Glu details
ABCC4 p.Lys498Glu
X
ABCC4 p.Lys498Glu 20799350:48:47
status:
NEW
view ABCC4 p.Lys498Glu details
ABCC4 p.Val1071Ile
X
ABCC4 p.Val1071Ile 20799350:48:65
status:
NEW
view ABCC4 p.Val1071Ile details
Experimentally characterized nsSNPs,
G487E
and
K498E
(NBD1), and
V1071I
(NBD2) are indicated in red.
Login to comment
50
ABCC6 p.Arg765Gln
X
ABCC6 p.Arg765Gln 20799350:50:178
status:
NEW
view ABCC6 p.Arg765Gln details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 20799350:50:327
status:
NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Arg560Ser
X
ABCC7 p.Arg560Ser 20799350:50:313
status:
NEW
view ABCC7 p.Arg560Ser details
ABCC7 p.Ala613Thr
X
ABCC7 p.Ala613Thr 20799350:50:758
status:
NEW
view ABCC7 p.Ala613Thr details
ABCC7 p.Arg560Lys
X
ABCC7 p.Arg560Lys 20799350:50:299
status:
NEW
view ABCC7 p.Arg560Lys details
ABCC7 p.Ala559Thr
X
ABCC7 p.Ala559Thr 20799350:50:162
status:
NEW
view ABCC7 p.Ala559Thr details
ABCC7 p.Asp614Gly
X
ABCC7 p.Asp614Gly 20799350:50:809
status:
NEW
view ABCC7 p.Asp614Gly details
ABCC7 p.Gly544Val
X
ABCC7 p.Gly544Val 20799350:50:430
status:
NEW
view ABCC7 p.Gly544Val details
ABCC7 p.Leu610Ser
X
ABCC7 p.Leu610Ser 20799350:50:633
status:
NEW
view ABCC7 p.Leu610Ser details
ABCB11 p.Ala570Thr
X
ABCB11 p.Ala570Thr 20799350:50:130
status:
NEW
view ABCB11 p.Ala570Thr details
ABCC8 p.Asp1471Asn
X
ABCC8 p.Asp1471Asn 20799350:50:412
status:
NEW
view ABCC8 p.Asp1471Asn details
ABCC9 p.Ala1513Thr
X
ABCC9 p.Ala1513Thr 20799350:50:725
status:
NEW
view ABCC9 p.Ala1513Thr details
ABCC8 p.Arg1493Trp
X
ABCC8 p.Arg1493Trp 20799350:50:230
status:
NEW
view ABCC8 p.Arg1493Trp details
ABCC8 p.Gly1478Arg
X
ABCC8 p.Gly1478Arg 20799350:50:447
status:
NEW
view ABCC8 p.Gly1478Arg details
ABCD1 p.Arg660Trp
X
ABCD1 p.Arg660Trp 20799350:50:534
status:
NEW
view ABCD1 p.Arg660Trp details
ABCD1 p.Thr668Ile
X
ABCD1 p.Thr668Ile 20799350:50:795
status:
NEW
view ABCD1 p.Thr668Ile details
ABCD1 p.Arg617Cys
X
ABCD1 p.Arg617Cys 20799350:50:249
status:
NEW
view ABCD1 p.Arg617Cys details
ABCD1 p.His667Asp
X
ABCD1 p.His667Asp 20799350:50:744
status:
NEW
view ABCD1 p.His667Asp details
ABCD1 p.Arg617His
X
ABCD1 p.Arg617His 20799350:50:285
status:
NEW
view ABCD1 p.Arg617His details
ABCD1 p.Arg660Pro
X
ABCD1 p.Arg660Pro 20799350:50:516
status:
NEW
view ABCD1 p.Arg660Pro details
ABCD1 p.Arg617Gly
X
ABCD1 p.Arg617Gly 20799350:50:267
status:
NEW
view ABCD1 p.Arg617Gly details
ABCA1 p.Ala2109Thr
X
ABCA1 p.Ala2109Thr 20799350:50:706
status:
NEW
view ABCA1 p.Ala2109Thr details
ABCA1 p.Met1091Thr
X
ABCA1 p.Met1091Thr 20799350:50:552
status:
NEW
view ABCA1 p.Met1091Thr details
ABCA1 p.Asp1099Tyr
X
ABCA1 p.Asp1099Tyr 20799350:50:776
status:
NEW
view ABCA1 p.Asp1099Tyr details
ABCA1 p.Ala1046Asp
X
ABCA1 p.Ala1046Asp 20799350:50:345
status:
NEW
view ABCA1 p.Ala1046Asp details
ABCA4 p.Arg2139Trp
X
ABCA4 p.Arg2139Trp 20799350:50:827
status:
NEW
view ABCA4 p.Arg2139Trp details
ABCA4 p.Glu2131Lys
X
ABCA4 p.Glu2131Lys 20799350:50:571
status:
NEW
view ABCA4 p.Glu2131Lys details
ABCA12 p.Glu1539Lys
X
ABCA12 p.Glu1539Lys 20799350:50:589
status:
NEW
view ABCA12 p.Glu1539Lys details
ABCA4 p.Arg1129Leu
X
ABCA4 p.Arg1129Leu 20799350:50:881
status:
NEW
view ABCA4 p.Arg1129Leu details
ABCA4 p.Glu1122Lys
X
ABCA4 p.Glu1122Lys 20799350:50:618
status:
NEW
view ABCA4 p.Glu1122Lys details
ABCA4 p.Arg1129Cys
X
ABCA4 p.Arg1129Cys 20799350:50:846
status:
NEW
view ABCA4 p.Arg1129Cys details
ABCA4 p.His2128Arg
X
ABCA4 p.His2128Arg 20799350:50:480
status:
NEW
view ABCA4 p.His2128Arg details
ABCB4 p.Ala546Asp
X
ABCB4 p.Ala546Asp 20799350:50:362
status:
NEW
view ABCB4 p.Ala546Asp details
ABCD1 p.Ala616Val
X
ABCD1 p.Ala616Val 20799350:50:148
status:
NEW
view ABCD1 p.Ala616Val details
ABCC8 p.Asp1471His
X
ABCC8 p.Asp1471His 20799350:50:394
status:
NEW
view ABCC8 p.Asp1471His details
ABCC8 p.Leu1543Pro
X
ABCC8 p.Leu1543Pro 20799350:50:650
status:
NEW
view ABCC8 p.Leu1543Pro details
ABCC8 p.Lys889Thr
X
ABCC8 p.Lys889Thr 20799350:50:498
status:
NEW
view ABCC8 p.Lys889Thr details
ABCC8 p.Arg1493Gln
X
ABCC8 p.Arg1493Gln 20799350:50:212
status:
NEW
view ABCC8 p.Arg1493Gln details
ABCC8 p.Arg841Gly
X
ABCC8 p.Arg841Gly 20799350:50:195
status:
NEW
view ABCC8 p.Arg841Gly details
Disease-associated nsSNPs at Three Structural Hotspots in Human ABC Transporter NBDs Gene Disease Position ARA motif ABCB11 BRIC2
A570T
ABCD1 X-ALD
A616V
CFTR CF
A559T
ABCC6 PXE
R765Q
ABCC8 HHF1
R841G
ABCC8 HHF1
R1493Q
ABCC8 HHF1
R1493W
ABCD1 X-ALD
R617C
ABCD1 X-ALD
R617G
ABCD1 X-ALD
R617H
CFTR CF
R560K
CFTR CF
R560S
CFTR CF
R560T
ABCA1 HDLD1
A1046D
ABCB4 ICP
A546D
C-loop 1 motif ABCC8 HHF1
D1471H
ABCC8 HHF1
D1471N
CFTR CBAVD
G544V
ABCC8 HHF1
G1478R
C-loop2 motif ABCA4 STGD1
H2128R
ABCC8 HHF1
K889T
ABCD1 X-ALD
R660P
ABCD1 X-ALD
R660W
ABCA1 HDLD2
M1091T
ABCA4 STGD1
E2131K
ABCA12 LI2
E1539K
ABCA4 STGD1 and CORD3
E1122K
CFTR CF
L610S
ABCC8 HHF1
L1543P
ABCA1 Colorectal cancer sample; somatic mutation
A2109T
ABCC9 CMD1O
A1513T
ABCD1 X-ALD
H667D
CFTR CF
A613T
ABCA1 HDLD2
D1099Y
ABCD1 X-ALD
T668I
CFTR CF
D614G
ABCA4 STGD1
R2139W
ABCA4 STGD1
R1129C
ABCA4 ARMD2, STGD1, and FFM
R1129L
Disease abbreviations are as follows: BRIC2, benign recurrent intrahepatic cholestasis type 2; X-ALD, X-linked adrenoleukodystrophy; CF, cystic fibrosis; PXE, Pseudoxanthoma elasticum; HHF1, familial hyperinsulinemic hypoglycemia-1; HDLD1, high density lipoprotein deficiency type 1; ICP, intrahepatic cholestasis of pregnancy; CBAVD, congenital bilateral absence of the vas deferens; STGD1, Stargardt disease type 1; HDLD2, high density lipoprotein deficiency type 2; LI2, ichthyosis lamellar type 2; CORD3, cone-rod dystrophy type 3; CMD1O, cardiomyopathy dilated type 1O; ARMD2, age-related macular degeneration type 2; FFM, fundus flavimaculatus.
Login to comment
62
ABCA4 p.His2128Arg
X
ABCA4 p.His2128Arg 20799350:62:51
status:
NEW
view ABCA4 p.His2128Arg details
Only one mutation affects the conserved histidine,
H2128R
in ABCA4.
Login to comment
72
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 20799350:72:1320
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Ile206Leu
X
ABCG2 p.Ile206Leu 20799350:72:1262
status:
NEW
view ABCG2 p.Ile206Leu details
ABCG2 p.Pro269Ser
X
ABCG2 p.Pro269Ser 20799350:72:1291
status:
NEW
view ABCG2 p.Pro269Ser details
ABCC6 p.Arg1268Gln
X
ABCC6 p.Arg1268Gln 20799350:72:1201
status:
NEW
view ABCC6 p.Arg1268Gln details
ABCC6 p.Ile742Val
X
ABCC6 p.Ile742Val 20799350:72:957
status:
NEW
view ABCC6 p.Ile742Val details
ABCC6 p.Arg724Lys
X
ABCC6 p.Arg724Lys 20799350:72:1017
status:
NEW
view ABCC6 p.Arg724Lys details
ABCB1 p.Ser1141Thr
X
ABCB1 p.Ser1141Thr 20799350:72:314
status:
NEW
view ABCB1 p.Ser1141Thr details
ABCB1 p.Pro1051Ala
X
ABCB1 p.Pro1051Ala 20799350:72:283
status:
NEW
view ABCB1 p.Pro1051Ala details
ABCB1 p.Thr1256Lys
X
ABCB1 p.Thr1256Lys 20799350:72:345
status:
NEW
view ABCB1 p.Thr1256Lys details
ABCB1 p.Val1251Ile
X
ABCB1 p.Val1251Ile 20799350:72:376
status:
NEW
view ABCB1 p.Val1251Ile details
ABCB1 p.Trp1108Arg
X
ABCB1 p.Trp1108Arg 20799350:72:407
status:
NEW
view ABCB1 p.Trp1108Arg details
ABCB11 p.Val444Ala
X
ABCB11 p.Val444Ala 20799350:72:221
status:
NEW
view ABCB11 p.Val444Ala details
ABCB11 p.Asn591Ser
X
ABCB11 p.Asn591Ser 20799350:72:159
status:
NEW
view ABCB11 p.Asn591Ser details
ABCB11 p.Glu592Gln
X
ABCB11 p.Glu592Gln 20799350:72:128
status:
NEW
view ABCB11 p.Glu592Gln details
ABCB11 p.Gln558His
X
ABCB11 p.Gln558His 20799350:72:190
status:
NEW
view ABCB11 p.Gln558His details
ABCB11 p.Glu1186Lys
X
ABCB11 p.Glu1186Lys 20799350:72:252
status:
NEW
view ABCB11 p.Glu1186Lys details
ABCC6 p.Pro664Ser
X
ABCC6 p.Pro664Ser 20799350:72:987
status:
NEW
view ABCC6 p.Pro664Ser details
ABCC6 p.Ala1291Thr
X
ABCC6 p.Ala1291Thr 20799350:72:1077
status:
NEW
view ABCC6 p.Ala1291Thr details
ABCC4 p.Gly487Glu
X
ABCC4 p.Gly487Glu 20799350:72:773
status:
NEW
view ABCC4 p.Gly487Glu details
ABCC4 p.Thr1142Met
X
ABCC4 p.Thr1142Met 20799350:72:864
status:
NEW
view ABCC4 p.Thr1142Met details
ABCC4 p.Lys498Glu
X
ABCC4 p.Lys498Glu 20799350:72:803
status:
NEW
view ABCC4 p.Lys498Glu details
ABCC3 p.Arg1381Ser
X
ABCC3 p.Arg1381Ser 20799350:72:742
status:
NEW
view ABCC3 p.Arg1381Ser details
ABCC2 p.Cys1515Tyr
X
ABCC2 p.Cys1515Tyr 20799350:72:498
status:
NEW
view ABCC2 p.Cys1515Tyr details
ABCC3 p.Gln1365Arg
X
ABCC3 p.Gln1365Arg 20799350:72:649
status:
NEW
view ABCC3 p.Gln1365Arg details
ABCC3 p.Arg1348Cys
X
ABCC3 p.Arg1348Cys 20799350:72:711
status:
NEW
view ABCC3 p.Arg1348Cys details
ABCC3 p.Arg1297His
X
ABCC3 p.Arg1297His 20799350:72:680
status:
NEW
view ABCC3 p.Arg1297His details
ABCC4 p.Val1071Ile
X
ABCC4 p.Val1071Ile 20799350:72:895
status:
NEW
view ABCC4 p.Val1071Ile details
ABCC4 p.Arg1220Gln
X
ABCC4 p.Arg1220Gln 20799350:72:833
status:
NEW
view ABCC4 p.Arg1220Gln details
ABCC3 p.Val765Leu
X
ABCC3 p.Val765Leu 20799350:72:619
status:
NEW
view ABCC3 p.Val765Leu details
ABCC2 p.Leu849Arg
X
ABCC2 p.Leu849Arg 20799350:72:468
status:
NEW
view ABCC2 p.Leu849Arg details
ABCC2 p.Ile670Thr
X
ABCC2 p.Ile670Thr 20799350:72:438
status:
NEW
view ABCC2 p.Ile670Thr details
ABCC3 p.Lys718Met
X
ABCC3 p.Lys718Met 20799350:72:559
status:
NEW
view ABCC3 p.Lys718Met details
ABCC6 p.Gly1327Glu
X
ABCC6 p.Gly1327Glu 20799350:72:1139
status:
NEW
view ABCC6 p.Gly1327Glu details
ABCC6 p.Arg769Lys
X
ABCC6 p.Arg769Lys 20799350:72:1047
status:
NEW
view ABCC6 p.Arg769Lys details
ABCC3 p.Thr809Met
X
ABCC3 p.Thr809Met 20799350:72:589
status:
NEW
view ABCC3 p.Thr809Met details
ABCC3 p.Asp770Asn
X
ABCC3 p.Asp770Asn 20799350:72:529
status:
NEW
view ABCC3 p.Asp770Asn details
ABCC6 p.Glu1369Lys
X
ABCC6 p.Glu1369Lys 20799350:72:1108
status:
NEW
view ABCC6 p.Glu1369Lys details
ABCC6 p.Leu1416Arg
X
ABCC6 p.Leu1416Arg 20799350:72:1170
status:
NEW
view ABCC6 p.Leu1416Arg details
ABCC6 p.Ile1330Leu
X
ABCC6 p.Ile1330Leu 20799350:72:926
status:
NEW
view ABCC6 p.Ile1330Leu details
ABCC6 p.Arg1461His
X
ABCC6 p.Arg1461His 20799350:72:1232
status:
NEW
view ABCC6 p.Arg1461His details
Predictions of the Functional Effects of 40 nsSNPs in ABC Transporters Comon name HUGO name Mutation NBD Prediction BSEP ABCB11
E592Q
NBD1 Neutral BSEP ABCB11
N591S
NBD1 Neutral BSEP ABCB11
Q558H
NBD1 Neutral BSEP ABCB11
V444A
NBD1 Neutral BSEP ABCB11
E1186K
NBD2 Disease MDR1 ABCB1
P1051A
NBD2 Neutral MDR1 ABCB1
S1141T
NBD2 Neutral MDR1 ABCB1
T1256K
NBD2 Disease MDR1 ABCB1
V1251I
NBD2 Neutral MDR1 ABCB1
W1108R
NBD2 Disease MRP2 ABCC2
I670T
NBD1 Disease MRP2 ABCC2
L849R
NBD1 Disease MRP2 ABCC2
C1515Y
NBD2 Disease MRP3 ABCC3
D770N
NBD1 Neutral MRP3 ABCC3
K718M
NBD1 Neutral MRP3 ABCC3
T809M
NBD1 Disease MRP3 ABCC3
V765L
NBD1 Disease MRP3 ABCC3
Q1365R
NBD2 Disease MRP3 ABCC3
R1297H
NBD2 Disease MRP3 ABCC3
R1348C
NBD2 Disease MRP3 ABCC3
R1381S
NBD2 Disease MRP4 ABCC4
G487E
NBD1 Disease MRP4 ABCC4
K498E
NBD1 Neutral MRP4 ABCC4
R1220Q
NBD2 Neutral MRP4 ABCC4
T1142M
NBD2 Neutral MRP4 ABCC4
V1071I
NBD2 Neutral MRP6 ABCC6
I1330L
NBD1 Neutral MRP6 ABCC6
I742V
NBD1 Neutral MRP6 ABCC6
P664S
NBD1 Neutral MRP6 ABCC6
R724K
NBD1 Neutral MRP6 ABCC6
R769K
NBD1 Neutral MRP6 ABCC6
A1291T
NBD2 Neutral MRP6 ABCC6
E1369K
NBD2 Neutral MRP6 ABCC6
G1327E
NBD2 Disease MRP6 ABCC6
L1416R
NBD2 Disease MRP6 ABCC6
R1268Q
NBD2 Disease MRP6 ABCC6
R1461H
NBD2 Disease MXR ABCG2
I206L
NBD1 Neutral MXR ABCG2
P269S
NBD1 Disease MXR ABCG2
Q141K
NBD1 Neutral nsSNPs.
Login to comment
78
ABCC4 p.Lys498Glu
X
ABCC4 p.Lys498Glu 20799350:78:4
status:
NEW
view ABCC4 p.Lys498Glu details
The
K498E
nsSNP was found with a frequency of 0.025 in the African-American population.
Login to comment
84
ABCC4 p.Gly487Glu
X
ABCC4 p.Gly487Glu 20799350:84:4
status:
NEW
view ABCC4 p.Gly487Glu details
The
G487E
nsSNP was found in only one Asian individual.
Login to comment
89
ABCC4 p.Val1071Ile
X
ABCC4 p.Val1071Ile 20799350:89:4
status:
NEW
view ABCC4 p.Val1071Ile details
The
V1071I
nsSNP was found in one African-American.
Login to comment
105
ABCC4 p.Gly487Glu
X
ABCC4 p.Gly487Glu 20799350:105:61
status:
NEW
view ABCC4 p.Gly487Glu details
ABCC4 p.Lys498Glu
X
ABCC4 p.Lys498Glu 20799350:105:4
status:
NEW
view ABCC4 p.Lys498Glu details
The
K498E
variant had no effect on MRP4 transport, while the
G487E
variant showed moderate reduction in function (P < 0.05, Fig. 7).
Login to comment
106
ABCC4 p.Val1071Ile
X
ABCC4 p.Val1071Ile 20799350:106:4
status:
NEW
view ABCC4 p.Val1071Ile details
The
V1071I
variant dramatically decreased TFV transport to $40% of the reference (P < 0.001; Fig. 7).
Login to comment
107
ABCC4 p.Val1071Ile
X
ABCC4 p.Val1071Ile 20799350:107:61
status:
NEW
view ABCC4 p.Val1071Ile details
Thus, two of the three predictions were validated, while the
V1071I
nsSNP prediction was invalidated.
Login to comment
110
ABCC4 p.Val1071Ile
X
ABCC4 p.Val1071Ile 20799350:110:17
status:
NEW
view ABCC4 p.Val1071Ile details
In contrast, the
V1071I
variant, which was predicted incorrectly, had significantly less expression on the plasma membrane compared with the reference (Supporting Information Fig. 2).
Login to comment
112
ABCC4 p.Gly487Glu
X
ABCC4 p.Gly487Glu 20799350:112:33
status:
NEW
view ABCC4 p.Gly487Glu details
ABCC4 p.Lys498Glu
X
ABCC4 p.Lys498Glu 20799350:112:40
status:
NEW
view ABCC4 p.Lys498Glu details
ABCC4 p.Val1071Ile
X
ABCC4 p.Val1071Ile 20799350:112:51
status:
NEW
view ABCC4 p.Val1071Ile details
Structural models of MRP4 nsSNPs
G487E
,
K498E
, and
V1071I
.
Login to comment
113
ABCC4 p.Gly487Glu
X
ABCC4 p.Gly487Glu 20799350:113:15
status:
NEW
view ABCC4 p.Gly487Glu details
ABCC1 p.Lys498Glu
X
ABCC1 p.Lys498Glu 20799350:113:25
status:
NEW
view ABCC1 p.Lys498Glu details
The models for
G487E
and
K498E
were based on the crystallographic structure of the human multidrug resistance protein MRP1 (PDB ID: 2CBZ).
Login to comment
114
ABCC4 p.Val1071Ile
X
ABCC4 p.Val1071Ile 20799350:114:14
status:
NEW
view ABCC4 p.Val1071Ile details
The model for
V1071I
was based on the structure of a multidrug resistance protein from Plasmodium yoelii (PDB ID: 2GHI).
Login to comment
146
ABCC4 p.Gly487Glu
X
ABCC4 p.Gly487Glu 20799350:146:372
status:
NEW
view ABCC4 p.Gly487Glu details
ABCC4 p.Lys498Glu
X
ABCC4 p.Lys498Glu 20799350:146:379
status:
NEW
view ABCC4 p.Lys498Glu details
ABCC4 p.Val1071Ile
X
ABCC4 p.Val1071Ile 20799350:146:390
status:
NEW
view ABCC4 p.Val1071Ile details
The distribution of disease-associated mutations is nonsymmetric in NBD1 and NBD2, rationalizing experimental work indicating that the two NBDs in an individual transporter are not functionally equivalent.34 Experimental characterization of ABCC4 nsSNPs and validation of a prediction model using a cell-based assay Predictions of functional impact of three ABCC4 nsSNPs (
G487E
,
K498E
, and
V1071I
) were chosen for experimental validation using HEK293 cells stably transfected with the reference transporter and its variants.
Login to comment
147
ABCC4 p.Gly487Glu
X
ABCC4 p.Gly487Glu 20799350:147:33
status:
NEW
view ABCC4 p.Gly487Glu details
Previously, we reported that the
G487E
nsSNP showed significantly reduced transport of two antiviral agents, azidothymidine and adefovir, compared with the reference following transient Figure 7.
Login to comment
153
ABCC4 p.Gly487Glu
X
ABCC4 p.Gly487Glu 20799350:153:38
status:
NEW
view ABCC4 p.Gly487Glu details
ABCC4 p.Gly487Glu
X
ABCC4 p.Gly487Glu 20799350:153:172
status:
NEW
view ABCC4 p.Gly487Glu details
ABCC4 p.Gly487Glu
X
ABCC4 p.Gly487Glu 20799350:153:299
status:
NEW
view ABCC4 p.Gly487Glu details
The decreased transport of TFV by the
G487E
variant is in accordance with previous reports using alternate substrates.29,35 Using Xenopus laevis oocytes, it was shown that
G487E
influenced the transport of 6-mercaptopurine and adefovir.35 As predicted, this effect could be due to the impact of the
G487E
nsSNP on the conformation of the loop near the membrane, which affects transporter function.
Login to comment
154
ABCC4 p.Gly487Glu
X
ABCC4 p.Gly487Glu 20799350:154:131
status:
NEW
view ABCC4 p.Gly487Glu details
ABCC4 p.Val1071Ile
X
ABCC4 p.Val1071Ile 20799350:154:158
status:
NEW
view ABCC4 p.Val1071Ile details
It is also consistent with the radical chemical change at this position, as quantified by the relatively higher Grantham value for
G487E
(D ¼ 98).36 The
V1071I
variant is buried and lies outside the range of known functional sites.
Login to comment
156
ABCC4 p.Val1071Ile
X
ABCC4 p.Val1071Ile 20799350:156:4
status:
NEW
view ABCC4 p.Val1071Ile details
The
V1071I
MRP4 variant shows a significant reduction in transport function (Fig. 7).
Login to comment
158
ABCC4 p.Val1071Ile
X
ABCC4 p.Val1071Ile 20799350:158:64
status:
NEW
view ABCC4 p.Val1071Ile details
The mechanism for the reduced plasma membrane expression of the
V1071I
variant remains unclear but may be related to changes in stability.
Login to comment
159
ABCC4 p.Lys498Glu
X
ABCC4 p.Lys498Glu 20799350:159:38
status:
NEW
view ABCC4 p.Lys498Glu details
Finally, the lack of an effect of the
K498E
variant on TFV transport is consistent with our prediction that this surface-exposed site is not affected by a change in charge.
Login to comment
162
ABCB1 p.Trp1108Arg
X
ABCB1 p.Trp1108Arg 20799350:162:4
status:
NEW
view ABCB1 p.Trp1108Arg details
The
W1108R
variant, predicted correctly by our algorithm to be deleterious (Table II), showed decreased resistance to the anticancer drugs daunorubicin and doxorubicin as well as to valinomycin, when compared with the reference P-glycoprotein in a yeast-based assay, suggesting a functional defect in the transporter.
Login to comment
163
ABCB1 p.Ser1141Thr
X
ABCB1 p.Ser1141Thr 20799350:163:17
status:
NEW
view ABCB1 p.Ser1141Thr details
In contrast, the
S1141T
variant showed either normal or increased transport in the yeast assay, suggesting that the transporter was functioning properly.37 This variant was correctly predicted to be neutral.
Login to comment
164
ABCB1 p.Ser1141Thr
X
ABCB1 p.Ser1141Thr 20799350:164:43
status:
NEW
view ABCB1 p.Ser1141Thr details
ABCB1 p.Val1251Ile
X
ABCB1 p.Val1251Ile 20799350:164:188
status:
NEW
view ABCB1 p.Val1251Ile details
Finally, in transfected HEK293T cells, the
S1141T
variant showed increased function, suggesting that the transporter is functioning normally, but also with substrate dependence as for the
V1251I
nsSNP.38 This variant was predicted correctly to be neutral.
Login to comment
165
ABCB1 p.Val1251Ile
X
ABCB1 p.Val1251Ile 20799350:165:4
status:
NEW
view ABCB1 p.Val1251Ile details
The
V1251I
variant of P-glycoprotein showed decreased transport of BODIPY-FL-paclitaxel, but increased transport of calcein-AM in an assay using transfected HEK293T cells.
Login to comment